Press Releases

ARUP’s New Institute for Research and Innovation in Diagnostic and Precision Medicine™ Will Forge the Future of Laboratory Medicine

New ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ will improve patient lives by advancing groundbreaking diagnostic and prognostic technologies.

ARUP Blood Services Implements Changes in Response to New FDA Guidelines on Blood Donor Assessment

The FDA now recommends the same assessment questions for all donors, regardless of gender or sexual orientation. ARUP Blood Services is one of the first donor centers to update processes in response.

FDA Approves ARUP Laboratories’ AAV5 DetectCDx™, a First-Ever Companion Diagnostic Immunoassay for a Gene Therapy

ARUP Laboratories has received FDA approval for its companion diagnostic immunoassay, AAV5 DetectCDx™, which helps determine patient eligibility for a new gene therapy for severe hemophilia A.

ARUP Laboratories Chooses Gestalt’s PathFlow Solution for Its Strategic Digital Initiatives

ARUP and Gestalt Diagnostics announced a partnership under which ARUP will adopt Gestalt’s PathFlow® platform as a foundation for future digital pathology initiatives.

Advanced Practice Clinical Laboratory Training Center at ARUP Secures $3 Million in Federal Funding

Efforts to train more medical laboratory scientists have been greatly boosted by $3 million in federal funds for a clinical lab training center that ARUP will build with the University of Utah.

Individuals Who Lived and Worked in Parts of Europe Now Eligible to Donate Blood

The U.S. Food and Drug Administration (FDA) has updated its guidelines to allow individuals who lived or worked in the United Kingdom, France, or Ireland to donate blood and platelets.

ARUP Honored With Utah Business Magazine’s Best Companies To Work For Award

ARUP’s culture of caring has earned it Utah Business magazine’s Best Companies To Work For Award for a fifth consecutive year.

ARUP Announces Successful Completion of CAP ISO 15189 Assessment

ARUP’s International Organization for Standardization (ISO) 15189 accreditation assessment has successfully concluded, and results confirm the consistently high quality of ARUP’s operations.

AAV5 DetectCDx™ Kit Is First ARUP Test Developed to Support a New Therapy

The European Commission’s approval of BioMarin’s novel gene therapy for severe hemophilia A has paved the way for ARUP’s AAV5 DetectCDx™ Kit to become the first ARUP-developed test used in Europe.

NanoSpot.ai Announces Partnership With Opto to Commercialize SARS-CoV-2 Antibody Test in Europe

NanoSpot.ai’s European commercialization agreement is the first for an antibody test originally developed through an ARUP/University of Utah/Techcyte partnership.

ARUP’s New Monkeypox Test Can Be Performed on More Specimen Types on High-Throughput Instruments

ARUP has launched a new, in-house test to detect the DNA of orthopoxviruses, including monkeypox.

New Executive Appointments Position ARUP Laboratories for Future Growth

Jonathan Genzen, MD, PhD, has been named chief medical officer and Adam Barker, PhD, has been named chief operations officer as part of a realignment of executive responsibilities.